Form 4: Mereo BioPharma Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Alexandra Hughes-Wilson, a Mereo BioPharma Group officer, sold shares to cover tax obligations, according to a recent SEC filing.
Summary
- Alexandra Hughes-Wilson, Chief Patient Access and Commercial Planning at Mereo BioPharma Group plc, reported transactions involving American Depositary Shares (ADS) representing ordinary shares.
- On May 22, 2024, Hughes-Wilson exercised options to acquire 93,333 ADSs at $1.4 and sold 50,350 ADSs at an average price of $2.99.
- Additionally, Hughes-Wilson exercised options to acquire 75,000 ADSs at $1.01 and sold 50,082 ADSs at an average price of $2.94.
- A total of 100,432 ADSs were sold to cover tax obligations.
- Following these transactions, Hughes-Wilson directly owns 7,650 ADSs.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing share transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The sale of shares by an officer could be perceived neutrally or slightly negatively by shareholders, depending on the context and the overall market sentiment.
Key Dates
| Date | Description |
|---|---|
| 01/14/2022 | 160,000 options were issued, vesting starting January 14, 2023. |
| 01/25/2023 | 240,000 options were issued, vesting starting January 25, 2024. |
| 01/14/2032 | Expiration date for share options with a strike price of $1.4. |
| 01/25/2033 | Expiration date for share options with a strike price of $1.01. |
| 05/22/2024 | Date of the reported transactions: exercising options and selling shares. |
| 05/23/2024 | Date of signature for the SEC filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.